Renalytix Plc (AIM:RENX)
London
· Delayed Price · Currency is GBP · Price in GBX 5.75
+0.24 (4.17%)
Aug 15, 2025, 4:35 PM GMT+1
Renalytix Market Cap
Renalytix has a market cap or net worth of 19.04 million as of August 15, 2025. Its market cap has decreased by -14.98% in one year.
Market Cap
19.04M
Enterprise Value
17.91M
Revenue
2.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.75
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 19.04M, a decrease of -70.51%. That is a compound annual growth rate of -16.49%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.46B |
| GSK plc | 57.85B |
| Haleon | 32.21B |
| Smith & Nephew | 11.81B |
| ConvaTec Group | 4.73B |
| Hikma Pharmaceuticals | 3.96B |
| Oxford Nanopore Technologies | 2.11B |
| HUTCHMED (China) | 2.01B |